NDC 66424-995 - Ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66424-995
- Manufacturer
- Contract Pharmacy Services-PA
- Effective date
- 2010-07-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ibuprofen - Contract Pharmacy Services-PA | Contract Pharmacy Services-PA | 2010-07-30 | HUMAN OTC DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| IBUPROFEN | ACTIVE INGREDIENT | WK2XYI10QM | IBUPROFEN TABLET [CONTRACT PHARMACY SERVICES-PA] | 1 | |
| IBUPROFEN | ACTIVE MOIETY | WK2XYI10QM | IBUPROFEN TABLET [CONTRACT PHARMACY SERVICES-PA] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Topcare Ibuprofen | IBUPROFEN | Topco Associates LLC | 742f33fa-8923-4415-bcd6-8db37f2e1974 | 2023-01-06 | Warnings | WK2XYI10QM |
| Flex-Prin | IBUPROFEN | Provision Medical Products | c01538b0-ca4c-434a-be8f-fe023deb84e1 | 2023-01-05 | Warnings | 310965 WK2XYI10QM |
| ibuprofen | IBUPROFEN | DOLGENCORP INC | 8f1358aa-495a-23da-e053-2995a90aa430 | 2023-01-02 | Warnings | 310965 WK2XYI10QM |
| Ibuprofen PM | IBUPROFEN, DIPHENHYDRAMINE HCL | TOP CARE (Topco Associates LLC) | c62c6319-65eb-37e8-e053-2a95a90a9f90 | 2022-12-28 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | WALGREEN COMPANY | 4ce20d2b-2dfb-4405-b545-dd1f67b2c588 | 2022-12-28 | Warnings | WK2XYI10QM |
| Migraine Relief | IBUPROFEN | WALGREENS | 3d560acb-3334-4a39-9ab1-f131060e3b33 | 2022-12-28 | Warnings | WK2XYI10QM |
| Dye-Free Ibuprofen 200 | IBUPROFEN | WALGREEN COMPANY | b9ff2469-22c7-fc70-e053-2a95a90abc49 | 2022-12-28 | Warnings | WK2XYI10QM |
| Dye-Free Ibuprofen 200 | IBUPROFEN | WALGREEN COMPANY | bcd15c0f-8231-296f-e053-2995a90a280c | 2022-12-28 | Warnings | WK2XYI10QM |
| Ibuprofen PM | IBUPROFEN, DIPHENHYDRAMINE HCL | Wal-Mart Stores, Inc. | ba31970a-b952-467c-b3f8-44f7a513de34 | 2022-12-28 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Wal-Mart Stores, Inc. | 9e5332ab-92bc-3a33-e053-2995a90a642d | 2022-12-28 | Warnings | WK2XYI10QM |
| Ibuprofen PM | IBUPROFEN, DIPHENHYDRAMINE HCL | CHAIN DRUG MARKETING ASSOCIATION INC. | c483bbd6-934b-660a-e053-2995a90a51b3 | 2022-12-27 | Warnings | WK2XYI10QM |
| Dye-Free Ibuprofen | IBUPROFEN | CHAIN DRUG MARKETING ASSOCIATION INC. | d0eff659-6445-a56a-e053-2995a90a72e9 | 2022-12-27 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Chain Drug Marketing Association, Inc. | 553d16e1-928e-4919-bc53-6683a035e2b0 | 2022-12-27 | Warnings | WK2XYI10QM |
| Ibuprofen PM | IBUPROFEN, DIPHENHYDRAMINE HCL | CVS Pharmacy | ce4378c0-848e-7878-e053-2a95a90af0f3 | 2022-12-27 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | KROGER COMPANY | 3b95dcbf-aef1-44b5-a2c4-5ce93c57ff1d | 2022-12-27 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | CHAIN DRUG MARKETING ASSOCIATION INC. | aa91952b-512f-0ead-e053-2995a90a9455 | 2022-12-21 | Warnings | WK2XYI10QM |
| Pediacare Childrens Ibuprofen Berry | IBUPROFEN | RANDOB LABS,LTD. DBA CROSSINGWELL CONSUMER HEALTH | 347d081f-068c-4173-9b4b-001ab2b891f5 | 2022-12-20 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Bionpharma Inc. | ba89fbe6-546a-e10c-e053-2a95a90ade0c | 2022-12-20 | Warnings | WK2XYI10QM |
| pain relief pm | IBUPROFEN, DIPHENHYDRAMINE HCL | Bionpharma Inc. | 58666a5c-fc92-4c8d-9c04-f0c98dc05c56 | 2022-12-20 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | INGLES MARKETS, INC. | ef536841-768c-919f-e053-2a95a90af599 | 2022-12-12 | Warnings | 310965 WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.